Table 3

Statin use among patients without prior CVD identified as being at risk

Total at risk (n (%))Number of at risk patients on statin, n (%)Number of untreated at risk patients, n (% total population)
FRS5/266 (1.6)1/5 (20)4/266 (1.5)
NCEP58/294 (21.7)3/64 (5.2)55/294 (18.7)
SCORE (TC:HDL)43/166 (25.9)18/43 (41.8)25/166 (15.1)
Reynolds Risk Score45/291 (15.5)5/45 (11.1)40/291 (13.7)
  • CVD, cardiovascular disease; FRS, Framingham Risk Score; HDL, high-density lipoproteins; LDL, low-density lipoproteins; NCEP, National Cholesterol Education Program; SCORE, systematic coronary risk evaluation according to total cholesterol: high-density lipoprotein risk tables; TC, total cholesterol.